ArticlePolymers2023
Characterization and Morphology of Nanocomposite Hydrogels with a 3D Network Structure Prepared Using Attapulgite-Enhanced Polyvinyl Alcohol.
Article in Polymers, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
2 citing papers in PubMed, 8 citations in OpenAlex.
- Advances and Challenges in 3D Bioprinting of Cartilage Organoids: From Material Innovation to Functional Regeneration.International journal of nanomedicine · 2026Review
- Effective adsorptive removal of triclosan from water using bio-nanocomposite hydrogel beads.Frontiers in chemistry · 2025Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors at 4 institutions in 2 countries.
Funding
Abstract
In this investigation, purified attapulgite (ATT) and polyvinyl alcohol (PVA) were utilized to fabricate nanocomposite hydrogels and a xerogel, with a focus on studying the impact of minor additions of ATT on the properties of the PVA nanocomposite hydrogels and xerogel. The findings demonstrated that at a concentration of 0.75% ATT, the water content and gel fraction of the PVA nanocomposite hydrogel reached their peak. Conversely, the nanocomposite xerogel with 0.75% ATT reduced its swelling and porosity to the minimum. SEM and EDS analyses revealed that when the ATT concentration was at or below 0.5%, nano-sized ATT could be evenly distributed in the PVA nanocomposite xerogel. However, when the concentration of ATT rose to 0.75% or higher, the ATT began to aggregate, resulting in a decrease in porous structure and the disruption of certain 3D porous continuous structures. The XRD analysis further affirmed that at an ATT concentration of 0.75% or higher, a distinct ATT peak emerged in the PVA nanocomposite xerogel. It was observed that as the content of ATT increased, the concavity and convexity of the xerogel surface, as well as the surface roughness, decreased. The results also confirmed that the ATT was evenly distributed in the PVA, and a combination of hydrogen bonds and ether bonds resulted in a more stable gel structure. The tensile properties exhibited that when compared with pure PVA hydrogel, the maximum tensile strength and elongation at break were achieved at an ATT concentration of 0.5%, indicating increases of 23.0% and 11.8%, respectively. The FTIR analysis results showed that the ATT and PVA could generate an ether bond, further confirming that ATT could enhance the PVA properties. The TGA analysis showed that the thermal degradation temperature peaked when the ATT concentration was at 0.5%, providing further evidence that the compactness of the nanocomposite hydrogel and the dispersion of the nanofiller was superior, contributing to a substantial increase in the mechanical properties of the nanocomposite hydrogel. Finally, the dye adsorption results displayed a significant rise in dye removal efficiency for methylene blue with the increase in the ATT concentration. At an ATT concentration of 1%, the removal efficiency rose by 103% compared with that of the pure PVA xerogel.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.